Weighted Average Number of Shares Outstanding, Basic of Poseida Therapeutics, Inc. from 30 Jun 2021 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Poseida Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2021 to 30 Sep 2024.
  • Poseida Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2024 was 97,160,467, a 5.7% increase year-over-year.
  • Poseida Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 90,185,096, a 25% increase from 2022.
  • Poseida Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 71,953,703, a 16% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Poseida Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 97,160,467 +5,262,120 +5.7% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 96,965,025 +10,170,328 +12% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 96,019,579 +9,754,356 +11% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 90,185,096 +18,231,393 +25% 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2024 2023 FY
Q3 2023 91,898,347 +15,610,926 +20% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 86,794,697 +24,081,334 +38% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2024 Q2
Q1 2023 86,265,223 +23,709,308 +38% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 71,953,703 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 76,287,421 +13,989,178 +22% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 62,713,363 +562,402 +0.9% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 62,555,915 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q3 2021 62,298,243 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 62,150,961 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2

Poseida Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 90,185,096 +18,231,393 +25% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2024 2023 FY
2022 71,953,703 +9,717,763 +16% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 62,235,940 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.